Trump approves US Steel-Nippon merger, pledging 70,000 jobs and $14B investment in the US economy.

The Federal Trade Commission will stop challenging Microsoft's acquisition of video game company Activision Blizzard.

Roman Kniazev, CEO of Nuravax, has emerged as one of biotech's most effective fundraisers, securing a mix of competitive grants and private investments to advance innovative drug programs. Kniazev shared some practical insights on navigating biotech's complex fundraising and clinical development landscape.

23andMe's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control and benefits.

Levi's sells Dockers to Authentic Brands for $311 million to focus on denim, global growth, and core brand strategy.

Japan's agriculture minister resigns after controversial rice comment amid rising food prices and public backlash.

Home Depot commits to keeping prices steady despite tariffs, setting itself apart from Walmart's planned price hikes.

Cucumbers recalled in 15 states after a Salmonella outbreak sickens 26 people and hospitalizes 9.

Elon Musk says he's cutting back on political donations after backing Trump with over $250 million in 2024.

Walmart CFO warns shoppers may see higher prices by late May due to rising import tariffs.